Methyldrostanolone (Superdrol) well known by bodybuilders as a strong anabolic steroid. First developed by Syntex in 1959. Unlike many other steroids was never commercialized as a prescription drug. It gained popularity in the 2000s as a "grey market" drug. Its non aromatizing nature prevents estrogenic effects like water retention, making it a favorite for cutting phases. However, its c-17 alpha alkylation, while enabling oral administration, also increases its risk of liver toxicity.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ

What is Methyldrostanolone?

Methyldrostanolone, also known as Superdrol, is a potent oral anabolic steroid and a derivative of dihydrotestosterone (DHT).

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What is the chemical structure of Methyldrostanolone?

Methyldrostanolone is a modified form of DHT, with a methyl group at carbon 17-alpha for oral bioavailability and a methyl group at carbon-2, increasing its anabolic strength.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What are the cardiovascular risks associated with Methyldrostanolone?

Methyldrostanolone can negatively affect cholesterol levels by reducing HDL (good cholesterol) and increasing LDL (bad cholesterol), potentially raising the risk of cardiovascular disease.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.